Category: Health Science
-
Cybin (CYBN.NE) establishes Clinical Advisory Board as they gear up for trials
Cybin (CYBN.NE) announced they are forming a Clinical Advisory Board, which will be chaired by Alex Belser, Cybin’s Chief Clinical Officer. The board will consist of Belser (PhD), Maurizio Fava (MD), Lynn Marie Morski (DM) and Anthony Back (MD). All members of the board have professional experience in either medicine or research. Fava, the Psychiatrist-in-Chief…
-
Predictmedix (PMED.C) Enters Partnership with Juiceworks and Connectus for Safe Entry Stations
Predictmedix (PMED.C) announced they are partnering with Juiceworks Exhibits and Connectus Global to deploy their Safe Entry Stations across the country. The Safe Entry Stations will use military-grade multispectral imaging, which captures things not immediately visible to the human eye. These multispectral cameras will be paired with Predictmedix’s proprietary, clinically based artificial intelligence algorithms which…
-
Perimeter Medical Imaging AI (PINK.V) latest study is the latest assault in the war on cancer
More than terrorism, drugs, racial animus and acts of God, cancer has always been with us. It’s humanity’s number one enemy throughout history—it’s only recently that we’ve learned what little we know, and devised rudimentary strategies on how to secure its defeat. The statistics are harrowing. Do a headcount next time during your commute then…
-
Predictmedix (PMED.C) engages global investment bank to prep for NASDAQ listing
The Nasdaq Exchange has 3,300 listed stocks including giants such as Apple (AAPL.Q), Google (GOOG.Q), Microsoft (MSFT.Q), Oracle (ORCL.Q), Amazon (AMZN.Q), and Intel (INTC.Q).
-
Parry Special: Short report on Mountain Valley MD Holdings (MVMD.C) earns nothing but rage
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to read much further. To open the discussion admitting you’ll make more money if the company you’re writing about gets obliterated, and then proceed to map out your obliteration strategy, well…
-
Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal…
-
As Australia opens to cannabis, Canntab’s (PILL.C) tech might just claim the box seat
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock into space. That’s understandable, to be honest, as North American investors have taken an eye off the island continent and its slow roll to weed legalization…
-
Heritage Cannabis (CANN.C) Receives Health Canada Export License
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking the first-ever license granting the export of CBD products from Canada to Brazil. “We are very pleased to be the first cannabis company in Canada to be granted an export…
-
Manganese X (MN.V) Subsidiary Receives Positive Preliminary Results on COVID Mitigating HVAC Filtration
Manganese X Energy’s (MN.V) wholly-owned subsidiary, Disruptive Battery, and their JV Partner, PureBiotic Air, have received positive preliminary results from their research study, being conducted in conjunction with Virginia State University (VSU). The study included the successful production of the biofilm required for further research and testing on PureBiotic’s HVAC (heating, ventilation, air conditioning) delivery…